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Charleston, WV
Objective:Although infection following carotid endarterectomy is rare, consequences of this seldom seen complication can
be devastating. Polyester, polytetrafluoroethylene (PTFE), and vein patches have all been used by many institutions for
patch angioplasty, each with reported cases of infection following surgery. Our institution has preferentially used PTFE
for the majority of cases, and here, we report our experience with postoperative infection following endarterectomy over
the last decade.
Methods: From January 2000 through July 2009, we treated infections following carotid endarterectomy in 25 patients.
Results: Of the 25 patients undergoing treatment for postoperative infection, 21 had PTFE patches placed during the
initial surgery. The remaining four consisted of two polyester patches and two bovine pericardial patches. Twenty-three
of the 25 initial endarterectomies were performed at our institution, and the other two were referrals. The majority of
cases (56%) were due to gram-positive organisms, with only two cases being polymicrobial. The interval from the original
surgery to clinical presentation ranged from 7 days to 85months, with 20 patients (80%) presenting within 60 days of the
first operation. Thirteen patients underwent incision and drainage with antibiotics, and 12 patients underwent definitive
surgical treatment. Four received patch excision with vein patch angioplasty, four received patch excision with vein
interposition, and four received sternocleidomastoid flaps. The 30-day stroke rate was 8%, and the freedom from
recurrent infection was 100% at a mean follow-up of 32 months.
Conclusion: Infection following carotid endarterectomy occurs <1% of the time; however, the potential for morbidity is
significant. Our results show that most infections following PTFE patch angioplasty occur in the early postoperative
period (<60 days) and that simple drainage with antibiotics may be an adequate form of treatment in select cases. ( J Vasc
Surg 2011;53:1473-7.)
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aSurgical site infection following any type of vascular oper-
ation can carry significant morbidity andmortality. Tradition-
ally, the highest rates of site infections are seen in the groin
following infrainguinal reconstructions. Clinical symptoms
can range frommild drainage to severe hemorrhaging. These
infections often require repeat procedures, lengthy hospital
stays, and the possibility of failed reconstructions.
Carotid endarterectomy has a very low incidence of post-
operative infection. There have been less than 100 reported
cases in the literature,withmore recent reviews demonstrating
a rate of 1%.1-6 A recent analysis demonstrated that pseu-
doaneurysms occur in 0.33% of carotid endarterectomies,
with 40% due to infection, which is the most common mani-
festation of carotid infection.1 Other presentations can in-
clude drainage, cellulitis, abscess, and even hemorrhage.
Herein, we report our experience with surgical site
infection following carotid endarterectomy with patch an-
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doi:10.1016/j.jvs.2011.02.020ioplasty over the last 10 years. Our institution has prefer-
ntially used polytetrafluoroethylene (PTFE) patches (the
cuseal patch; Gore Medical, Flagstaff, Ariz) for carotid
ndarterectomies during the study period. We examined
he onset and treatment of 25 patients with vascular surgi-
al site infections.
ATIENTS AND METHODS
This is a retrospective study of all carotid endarterecto-
ies done at Charleston AreaMedical Center from January
000 to July 2009 that required readmission and further
reatment for surgical site infection following carotid end-
rterectomy. Vascular, cardiothoracic, or general surgeons
erformed carotid endarterectomy procedures during this
tudy period. All readmissions following carotid endarter-
ctomy were evaluated based on hospital coding, and re-
iew of all cases that met criteria for surgical site infection
ere included. All initial operations were performed for
therosclerosis, and endarterectomy with patch angioplasty
as performed in a standard fashion. The selection of
atch, was predominantly PTFE; however, both Dacron
nd bovine pericardial patches were used as well, depending
n physician preference at the time of the procedure.
nfortunately, our review does not have the exact numbers
f each specific patch (ie, PTFE, Dacron) used during the
tudy period. From previous audit, we have estimated that
pproximately 80% of carotid patches used at our institu-
ion were PTFE over this time period.
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June 20111474 Stone et alThe clinical presentation (drainage, abscess, cellulitis,
etc) and the time interval from the initial carotid endarter-
ectomy to presentation were recorded. Patch infection was
diagnosed clinically, and all were confirmed with culture at
the time of admission. Antibiotics were started routinely on
admission, and continued for an extended period of time,
according to the sensitivity of each organism, allowing
adjustments to be made in the length and type of the
antibiotic regimen utilized.
Two treatment strategies were identified: conservative
treatment with patch preservation, which includes: antibi-
otics with local wound care, bedside incision and drainage
in seven patients with Szilagyi II infections; operative room
incision and drainage with intravenous antibiotics in six
patients; and incision/drainage with muscle flap in four
patients. The other strategy was patch excision, which
involves patch excision with vein patch angioplasty in four
patients and patch excision with interposition vein graft
repair in another four patients. Follow-up was recorded for
24 of 25 patients with infected carotid patches and ranged
from 1 month to 7 years. Only one patient was lost to
extended follow-up.
RESULTS
During the 10-year study period, approximately 4000
carotid endarterectomies were performed at our institu-
tion. Twenty-five of these patients were readmitted for
treatment of surgical site infection, resulting in an overall
infection rate of 1%. Twenty-three of these patients had
Table I. Demographics and presentation
Patient
Age
(years) Diabetes (Yes/No)
1 85 No
2 50 No
3 49 No
4 74 Yes
5 77 No
6 65 No
7 78 No
8 54 No
9 72 No
10 68 Yes
11 66 Yes
12 59 Yes
13 49 No
14 81 No
15 66 Yes
16 72 No
17 62 Yes
18 76 No
19 47 Yes
20 79 Yes
21 79 Yes
22 60 Yes
23 66 No
24 84 No
25 54 Yestheir original endarterectomies at Charleston Area Medical tenter, and the other two patients were referrals from
utside institutions.
Table I outlines the age, presence or absence of diabe-
es, time to and clinical presentation. The age ranged
etween 47 and 85 years, with a mean of 67 years. Diabetes
as present in 11 patients (44%). Three of the 25 patients
eveloped infection after redo carotid endarterectomy. The
ean time to presentation was 178 days, with average of 7
o 2555 days. Ten patients (40%) presented with purulent
rainage, three (12%) with serous drainage from the previ-
us surgical site. Five patients (20%) presented with an
bscess, and four patients (16%) presented with a pseudo-
neurysm, two of whom presented over a year after the
nitial surgery. Three patients (12%) presented with bleed-
ng from the surgical site: two with a neck hematoma, and
ne with a bleeding sinus tract.
Twenty-one of the 25 (84%) patients had PTFE
atches placed initially, two patients (8%) received a bovine
ericardial patch, and two (8%) received polyester patches.
eventeen patients had patch preservation: 10 patients were
aken to the operating room for incision/drainage and
ulture of perigraft fluid; four of these patients had their
TFE patches covered with a sternocleidomastoid muscle
ap. Seven other patients with Szilagyi II infections had
edside incision/drainage with cultures taken and antibi-
tics used for treatment. Tables II and III outline the types
f treatment, the type of patch used, and the bacterial
solate found for each infection, the follow-up length, and
ny complications encountered. The remaining eight pa-
Time to presentation (days) Clinical presentation
40 Bleed/purulent drainage
45 Purulent drainage
21 Purulent drainage
21 Abscess
21 Abscess
21 Abscess
180 Pseudoaneurysm
720 Pseudoaneurysm
360 Pseudoaneurysm
210 Pseudoaneurysm
12 Purulent drainage
10 Hematoma
42 Purulent drainage
2555 Bleeding sinus tract
14 Purulent drainage
17 Purulent drainage
26 Purulent drainage
33 Serous drainage
36 Serous drainage
7 Serous drainage
16 Abscess
14 Abscess/cellulitis
13 Purulent drainage
8 Purulent drainage
21 Hematomaients had patch excision (Table II). Four of these patients
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Volume 53, Number 6 Stone et al 1475received patch excision with vein patch angioplasty, and the
other four patients received patch excision with vein inter-
position repair.
For each reoperation, the wound cavity was reopened
in a standard fashion and drained of all purulent exudate.
Any debridement, if needed, was taken to healthy borders
of arterial tissue, and the decision as to what type of
treatment would be used was made intraoperatively by the
Table II. Patch excision with autologous repair
Patient Type of patch Bacterial isolate T
1 PTFE None VPA
2 PTFE S. epidermidis VPA
3 PTFE S. aureus VPA
4 PTFE None VPA
5 Polyester S. aureus Vein
6 Polyester None Vein
7 PTFE Enterobacter aerogenes Vein
8 PTFE Enterobacter aerogenes Vein
PTFE, Polytetrafluoroethylene; VPA, vein patch angioplasty.
Table III. Patch preservation
Patient OR/ surgeon Patch Presentation
9 CEA/GS PTFE Erythema with drainage No
10 CEA/GS PTFE Erythema with drainage No
11 CEA/GS PTFE Erythema with drainage No
12 CEA/GS PTFE Erythema with drainage No
13 Redo CEA/VS PTFE Erythema, purulent
drainage
CT
US
14 Redo w/ BPG/
VS
PTFE Bleeding from sinus
tract
CT
15 CEA/VS PTFE Erythema, purulent
drainage
US
16 CEA/repair PA/
CTS
PTFE Erythema, purulent
drainage
US
17 CEA/VS PTFE Purulent drainage CT
18 CEA/CTS PTFE Serous drainage CT
19 Redo CEA/CTS PTFE Erythema, serous
drainage
CT
20 CEA/CTS PTFE Serous drainage No
21 CEA/CTS Bovine Erythema, swelling, F/
C, leukocytosis
CT
22 CEA/CTS Bovine Pain, swelling, purulent
drainage
CT
23 CEA/CTS PTFE Swelling, purulent
drainage
US
24 CEA/GS PTFE Erythema, swelling,
purulent drainage
US
25 CEA/CTS PTFE Hematoma CT
BPG, Bypass graft; CEA, carotid endarterectomy; CT, computed tomograph
I/D, incision and drainage; MRSA, methicillin-resistant Staphylococcus aur
sensitive Staphylococcus aureus; OR, primary operation; PA, pseudoaneurys
vascular surgeon.
Imaging denoted as (), positive or (-), negative for deep space fluid collecattending surgeon, which varied greatly based on surgical ppeciality. Thirteen of the 17 patients managed with patch
reservation were not managed by vascular surgeons (car-
iothoracic or general surgeons), whereas all eight cases
ith patch excision and vein patch angioplasty or vein
nterposition were performed by a vascular surgeon.
If vein patch angioplasty was performed, shunting was
outinely instituted, followed by patch excision and de-
ridement. If interposition was carried out, excision of the
ent Follow-up period (months) Complication(s)
6 months Recurrent bleed
24 months None
6 months Hoarseness
12 months None
position 12 months None
position 12 months None
position 3 days (perioperative death) Stroke/death
position 24 months None
ing
Szilagyi
grade
Bacterial
isolate Treatment
Follow-up
(months)
III None Vancomycin IV 6
weeks
60
III None Vancomycin IV 6
weeks
3
III MSSA Rocephin IV 6 weeks 1
III MSSA Vancomycin 6 weeks 1
II MSSA Augmentin 2 weeks 72
II MRSE Doxycycline
suppression 2 years
44
II Proteus,
Serratia
Dapto/Pip IV, then
Bactrim 2 weeks
28
III E. aerogenes Rocephin, Bactrim
DS 2 weeks
0
II MSSA,
E. aerogenes
Augmentin 12 days 24
II MRSE Bactrim DS 5 days 62
II MRSE Vancomycin 7 days,
Doxycycline 30
days
16
II Negative Cipro 4 days 87
III S. agalactiae
(GroupB)
I/D abscess,
Rocephin 42 days
24
S() III S. agalactiae
(GroupB)
I/D abscess,
Rocephin 28 days
60
III MSSA I/D abscess,
Rocephin 21 days
3
III MRSA I/D abscess,
Vancomycin 14
days
24
III MRSA I/D, Bactrim 5 days 45
; CTS, cardiothoracic surgeon;DM, diabetes mellitus; GS, general surgeon;
RSE, methicillin-resistant Staphylococcus epidermidis; MSSA, methicillin-
D, postoperative day; PTFE, polytetrafluoroethylene; US, ultrasound; VS,
urrounding or extending to the endarterectomy site.reatm
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The standard vein used for each reoperation was the greater
saphenous vein, which was harvested from the thigh por-
tion of the saphenous vein, except in one patient who had
basilic vein harvest. In four patients, a sternocleidomastoid
muscle flap was used after incision and drainage. A muscle
flap with the stenocleidomastoid was performed to cover
the patch in these patients.
Microbiology results. Isolated gram-positive organ-
isms were found in 14 out of 25 patients (56%), with the
predominant organism being Staphylococcus aureus. Only
two of these isolates were found to be methicillin-resistant.
Of the nonstaphylococcal gram-positive species, Streptococ-
cus agalactiae was isolated from two patients and Staphylo-
coccus epidermidis grew from four patients. Gram-negative
isolates included Enterobacter aerogenes in three patients
(12%). Polymicrobial infections were seen in two patients
(8%), Proteus and Serratia species in one, and Staphylococcus
aureus and Enterobacter aerogenes in another. Six patients
(24%) had negative cultures despite clinical signs of infec-
tion. There appeared to be no difference in outcomes of
patients based on wound cultures.
Antibiotics were started on admission and included
broad-spectrum antibiotics for each patient. After appro-
priate sensitivities were obtained, the antibiotic regimen
was narrowed, and the regimen consisted of treatment from
2 to 4 weeks for the group that did not receive patch
removal treatment (Table III).
Follow-up revealed one event for the group treated
with patch preservation (Table III), and three postopera-
tive events (37.5%) occurred in the group of patients
treated with patch excision (Table II). One patient was
found to have a recurrent bleed from the site of re-explo-
ration within 7 days of vein patch angioplasty, which ap-
peared to be a technical error with cultures negative during
re-exploration. Additionally, one patient that had patch exci-
sion and vein patch angioplasty developed persistent hoarse-
ness.
Two patients suffered postoperative strokes secondary
to carotid occlusion. One patient had acute occlusion after
interposition vein grafting and returned to the operative
room from the recovery room, but suffered a fatal stroke
despite reestablishment of flow in the interposition repair.
The second patient was readmitted with a hemispheric
stroke approximately 30 days after muscle flap repair to the
infected carotid patch and did not undergo reexploration.
DISCUSSION
Infection following carotid surgery is one of the most
dreaded complications; fortunately, it occurs very infre-
quently. Several reports have analyzed the incidence of
infection after carotid endarterectomy with Dacron as well
as vein patch angioplasty. One of the first large reports, by
Rizzo et al, demonstrated that the incidence is quite low
but the morbidity can be significant, especially with surgical
repair.2 Dacron patch infections were treated with either
saphenous vein patching or grafting along with either oral
or intravenous antibiotics. Complications following repair pncluded cranial nerve injury, stroke, and myocardial infarc-
ion.2
A systemic review of the literature of Dacron patch
nfection following carotid endarterectomy by Knight et al
nalyzed 77 cases of carotid patch infections over the 12
ears, and found an overall rate of patch infection of 0.25%
o 0.50%. Neck swelling and pseudoaneurysms were found
o be the two most common presentations, and time to
iagnosis ranged anywhere from the perioperative period
o as long as 3 years after the initial operation. The majority
f infections were due to gram-positive organisms, which
ncluded Staphylococcus aureus, (both methicillin-resistant
nd -sensitive) and Staphylococcus epidermidis. Occasion-
lly, other organisms were encountered, such as Bacteroides
ragilis and Pseudomonas species, but these constituted a
mall minority. The overall rates for perioperative stroke
nd death were 6% and 5%, respectively. Cranial nerve
njury and reinfection carried the highest occurrence rates
t 8%.6
To the best of our knowledge, our series of 25 patients
21 of whom had PTFE) with surgical site infection follow-
ng carotid endarterectomy is the largest series to date. Our
esults show that infections for PTFE patches carry the
ame variable time to presentation as seen with most series
f Dacron patches, an average of 178 days, with most
20/25; 80%) presenting within 60 days of the initial
urgery. The majority of patients presented with drainage,
nd only 16% and 20% of patients presented with a pseu-
oaneurysm and abscess, respectively, in our series. Fifty-six
ercent of all infections were due to gram-positive bacteria,
hich is concordant with most reviews; however, our series
ad a significant proportion of patients who had negative
ultures (24%).
This is also the first large series to evaluate conservative
atch preservation treatment (antibiotics with or without
imple drainage) versus standard surgical therapy (patch
xcision) in the treatment of surgical site infections follow-
ng carotid endarterectomy and their long-term outcomes.
ll 13 patients that were treated with drainage and/or
ntibiotic therapy had Szilagyi Class II or III infections, and
he decision of treatment repair was made during the initial
valuation.
Carotid surgery at our institution has been a high
olume procedure over the past decade. Until 5 years ago,
single vascular surgeon was present, with the other sur-
eons trained as either general or cardiothoracic surgery.
anagement strategies can vary with the surgeons’ back-
round of training; none of the patch excision surgical
rocedures were performed by cardiothoracic surgeons, all
our of the muscle flaps were performed by general sur-
eons in our institutions, and all definitive repairs, includ-
ng patch excision, were performed by vascular surgeons.
here were no standard criteria for patch preservation since
here was such a heterogeneous group of surgeons treating
hese patients. Freedom from recurrent infection in our
ollow-up was 100% at a mean interval of 32 months. It is
lso important to recognize that one patient treated with
atch excision and one with patch preservation had a post-
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Volume 53, Number 6 Stone et al 1477operative stroke. In addition to stroke, cranial nerve injury
is also a well-known complication that can occur with
surgical treatment, which was noted in one of the eight
patients treated with patch excision in our group.
Of interest, the results with either patch preservation
with simple drainage or muscle flap had similar long-term
results when compared with patch excision. Based on our
single institution experience with this rare problem, we
suggest the following treatment algorithm. Infected ca-
rotid patch removal is mandatory in cases of pseudoaneu-
rysm or sepsis, especially with gram-negative and anaerobes
as a culprit organism. Graft preservation appears reasonable
even when infected perigraft fluid is present in patients with
PTFE patch or bovine pericardial patch. Only two patients
in our series had Dacron patches, both of which were
removed; therefore, we cannot make recommendations of
conservative treatment based on these limitations.
Our study has many of the limitations seen in a retro-
spective study. Our cohort also did not define any standard
criteria for evaluating patients as candidates for conservative
patch preservation versus definitive treatment of patch ex-
cision. Secondary to this, no definitive statements can be
made when comparing the two treatment groups. There is
also the possibility that a patient that developed a carotid
patch infection may not have had follow-up at our institu-
tion, and that surgical site infection rates may not be
accurate. Also, the majority of patients who had carotid
endarterectomy were treated with PTFE patches, and there
was a low proportion of patients treated with polyester
patches. Unfortunately, a more definitive prospective study
is not feasible secondary to the extremely low frequency of
this complication, and retrospective reviews will continue
to assist surgeons in evolving treatment options for these
infrequent complications.
CONCLUSION
Infection following carotid endarterectomy occurs
1% of the time; however, the potential for morbidity is Significant. Our results show that most infections following
TFE patch angioplasty occur in the early postoperative
eriod (60 days). Patch preservation with and incision/
rainage with or without muscle flap and antibiotics may be
onsidered in patients with PTFE infections that are not
eptic or with pseudoaneurysms.
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